ConductScience.org, home

Paper277246

Clinical studies with misonidazole.

Wiltshire CR and 3 others. Br J Cancer Suppl, 1978. Cited by 40 papers, by iCite.

Cite this record

ConductScience Library. Clinical studies with misonidazole. Papers, record 277246. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/277246

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical studies with misonidazole.
PubMed
Journal
Br J Cancer Suppl
PubMed
Year
1978
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
40
iCite
Relative citation ratio, by iCite
1.43
iCite
Revised in PubMed
2018-11-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wiltshire CRC R
2Workman PP
3Watson JVJ V
4Bleehen NMN M

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AstrocytomaMajor topic
Brain NeoplasmsMajor topic
NitroimidazolesMajor topic
Radiation-Sensitizing AgentsMajor topic
Adult
Breast Neoplasms
Humans
Random Allocation
Time Factors

Source PubMed

Download CSV of topics

References9

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1861146Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses.Br J Cancer1977https://conductscience.org/library/papers/861146PubMed
21016978Radiosensitizers of hypoxic cells in solid tumors.Cancer Treat Rev1976https://conductscience.org/library/papers/1016978PubMed
3177873Radiation and high-dose metronidazole in supratentorial glioblastomas.N Engl J Med1976https://conductscience.org/library/papers/177873PubMed
4776494Clinical testing of the radiosensitiser Ro-07-0582. III. Response of tumours.Clin Radiol1976https://conductscience.org/library/papers/776494PubMed
5776493Clinical testing of the radiosensitiser Ro-07-0582. I. Dose tolerance, serum and tumour concentrations.Clin Radiol1976https://conductscience.org/library/papers/776493PubMed
61162051Phase 1 study of high-dose metronidazole: a specific in vivo and in vitro radiosensitizer of hypoxic cells.Radiology1975https://conductscience.org/library/papers/1162051PubMed
71174445Serum concentration measurements in man of the radiosensitizer Ro-07-0582: some preliminary results.Br J Cancer1975https://conductscience.org/library/papers/1174445PubMed
810881705Hypoxic cell radiosensitizers: comparative tests of some electron affinic compounds using epidermal cell survival in vivo.Radiat Res1974https://conductscience.org/library/papers/10881705PubMed
910881704Electron affinic sensitization. V. Radiosensitization of hypoxic bacteria and mammalian cells in vitro by some nitroimidazoles and nitropyrazoles.Radiat Res1974https://conductscience.org/library/papers/10881704PubMed

Download CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.

PMIDTitleJournalYearIn PapersSource
7370166Pharmacokinetic and tumour-penetration properties of the hypoxic cell radiosensitizer desmethylmisonidazole (Ro 05-Ro-9963) in dogs.Br J Cancer1980https://conductscience.org/library/papers/7370166PubMed
7225286Cytotoxicity of metronidazole (Flagyl) and misonidazole (Ro-07-0582): enhancement by lactate.Br J Cancer1981https://conductscience.org/library/papers/7225286PubMed
7059476The penetration of misonidazole into a mature structural cartilage.Br J Cancer1982https://conductscience.org/library/papers/7059476PubMed
7016157A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma.Br J Cancer1981https://conductscience.org/library/papers/7016157PubMed
743488Monitoring salivary misonidazole in man: a possible alternative to plasma monitoring.Br J Cancer1978https://conductscience.org/library/papers/743488PubMed
465300Pharmacokinetic considerations in testing hypoxic cell radiosensitizers in mouse tumours.Br J Cancer1979https://conductscience.org/library/papers/465300PubMed
289406The penetration of misonidazole into spontaneous canine tumours.Br J Cancer1979https://conductscience.org/library/papers/289406PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/277246

GET https://conductscience.org/api/papers/v1/277246/authors